Henri J. Huttunen

PhD, Chief Scientific Officer

Henri Huttunen co-founded Herantis Pharma Plc. in 2008 and served as the company’s founding CEO until February 2010. Dr. Huttunen is currently the Chief Scientific Officer of Herantis, and has also served as member of the Board of Directors until April 2014. Dr. Huttunen has previously held research positions at the University of Helsinki, Orion Pharma, and Massachusetts General Hospital, Harvard Medical School (USA). Dr. Huttunen has a PhD in biochemistry from the University of Helsinki and more than 15 years of experience in neuroscience research. As an adjunct professor, Dr. Huttunen also leads an academic research group focusing in molecular mechanisms of neurodegenerative diseases at the Neuroscience Center, University of Helsinki.